University of Cambridge > Talks.cam > Cambridge Oncology Seminar Series > Pathway Analysis of Glioblastoma Tissue After Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib – A Phase “0 Trial”

  Browse A-Z

Log in

University Account External (via Google)

🔐 Log In

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

ℹ️ Information

Pathway Analysis of Glioblastoma Tissue After Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib – A Phase “0 Trial”

Download to your calendar using vCal

  • UserDr Monika Hegi, University Hospital (CHUV), Lausanne, Switzerland
  • ClockTuesday 21 September 2010, 12:00-13:00
  • HouseCRI Lecture Theatre.

If you have a question about this talk, please contact Mala Jayasundera .

Abstract not available

This talk is part of the Cambridge Oncology Seminar Series series.

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

LT2, Engineering, Department of Webinar & LT2, Computer Laboratory, William Gates Building. Lewin Stroke & Rehabilitation Unit, Seminar Room, R2, Addenbrooke's Hospital

Other talks

Title to be confirmed Cooperation for Nature Group Work title and abstract tba (joint seminar with Spectral Geometry in the Clouds) TBC Tea and Coffee Break
 

© 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity